Predictive factors for a successful mobilization of peripheral blood CD34 + cells in multiple myelomaG Perea, Jorge Sierra, C. Mart x ED nez et al.|Annals of Hematology|2001Cited by 81
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2023Cited by 62